Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $9,100,000 | reported | |
| FY 2024 | 2024-12-31 | $9,085,000 | reported | |
| FY 2023 | 2023-12-31 | $7,789,000 | reported | |
| FY 2022 | 2022-12-31 | $8,180,000 | reported | |
| FY 2021 | 2021-12-31 | $7,176,000 | reported | |
| FY 2020 | 2020-12-31 | $7,128,000 | reported | |
| FY 2019 | 2019-12-31 | $9,472,000 | reported | |
| FY 2018 | 2018-12-31 | $11,089,000 | reported | |
| FY 2017 | 2017-12-31 | $7,456,000 | reported | |
| FY 2016 | 2016-12-31 | $7,165,000 | reported | |
| FY 2015 | 2015-12-31 | $7,551,000 | reported | |
| FY 2014 | 2014-12-31 | $7,017,000 | reported |
International Stem Cell CORP · CIK 1355790 · Engraved from SEC EDGAR
Twelve months to Jun 30, 2026 · derived
International Stem Cell CORP is the 173rd largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834
Latest filing Nov 17, 2026
The us-gaap concepts with the most facts on file for this company.
Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
No Form 13F holders on file yet.
1 transaction